Shaha, Kunal Bikram, et al. “Angiotensin-Converting Enzyme Inhibitor Angiotensin II Receptor Blocker in COVID-19: A Double-Edged Sword or a Myth”. Nepalese Medical Journal, vol. 3, no. 1, May 2020, pp. 309-12, doi:10.3126/nmj.v3i1.28726.